參考文獻/References:
[1] Riazi K,Azhari H,Charette J H,et al.The prevalence and incidence of NAFLD worldwide:a systematic review and meta-analysis[J].The Lancet Gastroenterology & Hepatology,2022,7(9):851-861.
[2] Yip T C,Vilar-Gomez E,Petta S,et al.Geographical simil-arity and differences in the burden and genetic predisposition of NAFLD[J].Hepatology,2023,77(4):1404-1427.
[3] Tanase D M,Gosav E M,Costea C F,et al.The intricate relationship between type 2 diabetes mellitus(T2DM),insulin resistance(IR),and nonalcoholic fatty liver disease(NAFLD)[J].Journal of diabetes research,2020,2020:3920196.
[4] Papandreou D,Andreou E.Role of diet on non-alcoholic fatty liver disease:an updated narrative review[J].World Journal of Hepatology,2015,7(3):575-582.
[5] Haigh L,Kirk C,El Gendy K,et al.The effectiveness and acceptability of mediterranean diet and calorie restriction in non-alcoholic fatty liver disease(NAFLD):a systematic review and meta-analysis[J].Clinical Nutrition(Edinburgh,Scotland),2022,41(9):1913-1931.
[6] Al-Khudairy L,Loveman E,Colquitt J L,et al.Diet,physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years[J].Cochrane Database Syst Rev,2017,6(6):CD012691.
[7] Ericson E,Bergenholm L,Andréasson A C,et al.Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans[J].Hepatology Communications,2022,6(10):2689-2701.
[8] Obara N,Fukushima K,Ueno Y,et al.Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice[J].Journal of Hepatology,2010,53(2):326-334.
[9] Tetri L H,Basaranoglu M,Brunt E M,et al.Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent[J].American Journal of Physiology Gastrointestinal and Liver Physiology,2008,295(5):987-995.
[10] Paik J M,Mir S,Alqahtani S A,et al.Dietary risks for liver mortality in NAFLD:global burden of disease data[J].Hepatology Communications,2022,6(1):90-100.
[11] 中華醫(yī)學會肝臟病學分會脂肪肝和酒精性肝病學組.非酒精性脂肪性肝病診療指南[J].中國肝臟病雜志:電子版,2010(4):43-48.
[12] Eslamparast T,Poustchi H,Zamani F,et al.Synbiotic supplementation in nonalcoholic fatty liver disease:a randomized,double-blind,placebo-controlled pilot study[J].The American Journal of Clinical Nutrition,2014,99(3):535-542.
[13] Faghihzadeh F,Adibi P,Hekmatdoost A.The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease:a randomised,double-blind,placebo-controlled study[J].The British Journal of Nutrition,2015,114(5):796-803.
[14] Hekmatdoost A,Shamsipour A,Meibodi M,et al.Adherence to the dietary approaches to stop hypertension(DASH)and risk of nonalcoholic fatty liver disease[J].International Journal of Food Sciences and Nutrition,2016,67(8):1024-1029.
[15] Tajima R,Kimura T,Enomoto A,et al.Association between rice,bread,and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women[J].Clinical nutrition(Edinburgh,Scotland),2017,36(6):1601-1608.
[16] Pixner T,Stummer N,Schneider A M,et al.The role of macronutrients in the pathogenesis,prevention and treatment of non-alcoholic fatty liver disease(NAFLD)in the paediatric population-A review[J].Life(Basel,Switzerland),2022,12(6):839.
[17] Dhibi M,Brahmi F,Mnari A,et al.The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease(NAFLD)in rats[J].Nutrition & Metabolism,2011,8(1):65.
[18] Bravo E,Palleschi S,Aspichueta P,et al.High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway[J].Lipids in Health and Disease,2011,10:60.
[19] Dashti N,Feng Q,Freeman M R,et al.Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells[J].The Journal of Nutrition,2002,132(9):2651-2659.
[20] Mitmesser S H,Carr T P.Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells[J].The Journal of Nutritional Biochemistry,2005,16(3):178-183.
[21] Mensink R P,Zock P L,Kester A D,et al.Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins:a meta-analysis of 60 controlled trials[J].The American Journal of Clinical Nutrition,2003,77(5):1146-1155.
[22] Mozaffarian D,Rimm E B,King I B,et al.Trans fatty acids and systemic inflammation in heart failure[J].The American Journal of Clinical Nutrition,2004,80(6):1521-1525.
[23] Jacome-Sosa M M,Borthwick F,Mangat R,et al.Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome[J].The Journal of Nutritional Biochemistry,2014,25(7):692-701.
[24] Lopez-Garcia E,Schulze M B,Meigs J B,et al.Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction[J].The Journal of Nutrition,2005,135(3):562-566.
[25] Sun Q,Ma J,Campos H,et al.A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease[J].Circulation,2007,115(14):1858-1865.